1. Home
  2. PLRX vs NDMO Comparison

PLRX vs NDMO Comparison

Compare PLRX & NDMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pliant Therapeutics Inc.

PLRX

Pliant Therapeutics Inc.

N/A

Current Price

$1.11

Market Cap

73.7M

Sector

Health Care

ML Signal

N/A

Logo Nuveen Dynamic Municipal Opportunities Fund of Beneficial Interest

NDMO

Nuveen Dynamic Municipal Opportunities Fund of Beneficial Interest

N/A

Current Price

$9.13

Market Cap

601.2M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
PLRX
NDMO
Founded
2015
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
73.7M
601.2M
IPO Year
2020
2019

Fundamental Metrics

Financial Performance
Metric
PLRX
NDMO
Price
$1.11
$9.13
Analyst Decision
Hold
Analyst Count
4
0
Target Price
$2.67
N/A
AVG Volume (30 Days)
408.2K
187.3K
Earning Date
05-06-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
29.97
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.02
$9.37
52 Week High
$1.95
$10.82

Technical Indicators

Market Signals
Indicator
PLRX
NDMO
Relative Strength Index (RSI) 48.64 13.54
Support Level $1.12 N/A
Resistance Level $1.26 $10.47
Average True Range (ATR) 0.04 0.14
MACD -0.00 -0.06
Stochastic Oscillator 27.69 0.00

Price Performance

Historical Comparison
PLRX
NDMO

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.

About NDMO Nuveen Dynamic Municipal Opportunities Fund of Beneficial Interest

Nuveen Dynamic Municipal Opportunities is a closed-end management investment company. Its investment objective is to seek total return through income exempt from regular federal income taxes and capital appreciation. A majority of its investments are made in municipal securities, the income from which is exempted from regular federal income taxes.

Share on Social Networks: